DC ChemicalsChemicals for Life Science
sales@dcchemicals.com

DCL0001 · Updated 24 October 2026

Antioxidant lipid AO16
Literature records

Search the tables and observations reproduced from the product literature guide. Rows may represent measurements, recipes or experimental context; they are not all independent experiments.

Literature-reported formulation composition

Component: AO16 | Reported molar ratio: 2.50 | Normalized mol%: 2.44 | Role: Ionizable lipid

Literature-reported formulation composition

Component: SM-102 | Reported molar ratio: 50.00 | Normalized mol%: 48.78 | Role: Ionizable lipid

Literature-reported formulation composition

Component: DSPC | Reported molar ratio: 10.00 | Normalized mol%: 9.76 | Role: Helper phospholipid

Literature-reported formulation composition

Component: Cholesterol | Reported molar ratio: 38.50 | Normalized mol%: 37.56 | Role: Sterol

Literature-reported formulation composition

Component: DMG-PEG2000 | Reported molar ratio: 1.50 | Normalized mol%: 1.46 | Role: PEG lipid

Literature-reported formulation composition

Component: Reported ratio sum | Reported molar ratio: 102.50 | Normalized mol%: 100.00 | Role: AO16 addition relative to SM-102

Reported observation

Literature-reported Antioxidant score at 0.05 mM 67% for AO16 LNPs versus 57% for the commercial control LNP Reactive species panel: O2−, ·OH, H2O2, ClO− and ONOO−; 5 mol% AO16 relative to SM-102 Supplementary Information p. 76, Supplementary Table 2.

Reported observation

Literature-reported Antioxidant score at 0.50 mM 32% for AO16 LNPs versus 37% for the commercial control LNP Same five-species panel at the higher challenge concentration Supplementary Information p. 78, Supplementary Table 2.

Reported observation

Literature-reported Reactive-species values at 0.05 mM O2− 87; ·OH 42; H2O2 72; ClO− 69; ONOO− 64 These are the source table values used to calculate the reported average score of 67. Supplementary Information p. 76, Supplementary Table 2.

Reported observation

What the source supports The cited article supports AO16 as an in vitro antioxidant-lipid screening candidate with the formulation and challenge conditions listed above. Nature Communications 2026;17:7166; DOI 10.1038/s41467-026-73512-3.

Reported observation

What is not assigned to AO16 AO12 was the lead selected for the paper's later regeneration, biodistribution and gene-editing experiments. Those AO12-specific animal results are not presented as AO16 product performance. Product-page evidence boundary.

Open the complete guide for source context →